Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dose Optimization Informed by PBPK Modeling: State‐of‐the Art and Future
Karen Rowland Yeo, Eva Gil Berglund, Yuan Chen
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 563-576
Open Access | Times Cited: 17

Showing 17 citing articles:

Regulatory Trends of Organophosphate and Pyrethroid Pesticides in Cannabis and Applications of the Comparative Toxicogenomics Database and Caenorhabditis elegans
Argelis Rivera, Ariell B. Stephens, Kendra D. Conrow, et al.
Toxicological Sciences (2025)
Closed Access
High-performance PBPK model for predicting CYP3A4 induction-mediated drug interactions: a refined and validated approach
Cheng-guang Yang, Tao Chen, Wenteng Si, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Considering Opportunities and Challenges When Implementing the Model Master File Framework – a Meeting Report
Eleftheria Tsakalozou, Lanyan Fang, Erin Skoda, et al.
Pharmaceutical Research (2025)
Open Access
Drug–drug interaction study with itraconazole supplemented with physiologically based pharmacokinetic modelling to characterize the effect of CYP3A inhibitors on venglustat pharmacokinetics
Li Li, Yanyan Zhang, Jyoti Sharma, et al.
British Journal of Clinical Pharmacology (2025)
Closed Access
Cherishing Professional Success and Personal Fulfillment: Resilience as a Pivotal Leadership Competency for Clinical Pharmacologists and Beyond
Karthik Venkatakrishnan, Jing Zhu, Federica Ferrari, et al.
The Journal of Clinical Pharmacology (2025)
Closed Access
A new paradigm for drug discovery in the treatment of complex diseases: drug discovery and optimization
Yu Yuan, Lu-Lu Yu, Chenghao Bi, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Model‐Based Pharmacokinetic Approaches
Manish P. Patel, Kashyap M. Patel, Shakil Z. Vhora, et al.
(2025), pp. 11-51
Closed Access
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
Arthur Géraud, Paul Gougis, Alexandre de Nonneville, et al.
Cancer Treatment Reviews (2025), pp. 102922-102922
Closed Access
Multiobjective Optimization of Biological and Physical Properties in Drug Discovery
M. Paul Gleeson, Dino Montanari
Elsevier eBooks (2025)
Closed Access
Physiologically Based Pharmacokinetic (PBPK) Model to Predict the Magnitude of Drug–Drug Interaction Between Fezolinetant and CYP1A2 Inhibitors
Mary Choules, Yukio Otsuka, Jace Nielsen, et al.
The Journal of Clinical Pharmacology (2025)
Open Access
Innovative Approaches to Optimize Clinical Transporter Drug–Drug Interaction Studies
Sabina Paglialunga, Natacha Benrimoh, Aernout D. van Haarst
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 992-992
Open Access | Times Cited: 3
Safety and Efficacy of Antiviral Drugs and Vaccines in Pregnant Women: Insights from Physiologically Based Pharmacokinetic Modeling and Integration of Viral Infection Dynamics
Bárbara Costa, Maria João Gouveia, Nuno Vale
Vaccines (2024) Vol. 12, Iss. 7, pp. 782-782
Open Access | Times Cited: 2
Getting the Dosage Right: A Vital Role for Clinical Pharmacology in the Era of Precision Medicine
Iris K. Minichmayr, Mohamad Shebley, Piet H. van der Graaf, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 116, Iss. 3, pp. 491-496
Open Access | Times Cited: 2
Infliximab in Inflammatory Bowel Disease: Leveraging Physiologically Based Pharmacokinetic Modeling in the Clinical Context
Zvonimir Petrić, João Gonçalves, Paulo Paixão
Biomedicines (2024) Vol. 12, Iss. 9, pp. 1974-1974
Open Access | Times Cited: 1
Recent Advances in Omics, Computational Models, and Advanced Screening Methods for Drug Safety and Efficacy
Areum Sohn, Jongham Park, Woojin Kim, et al.
Toxics (2024) Vol. 12, Iss. 11, pp. 822-822
Open Access | Times Cited: 1
Clinical and Physiologically Based Pharmacokinetic Model Evaluations of Adagrasib Drug–Drug Interactions
Cornelius Cilliers, Eleanor Howgate, Hannah M. Jones, et al.
Clinical Pharmacology & Therapeutics (2024)
Open Access | Times Cited: 1
Utilizing Omics Technologies and Machine Learning to Improve Predictive Toxicology
Ahrum Son, Jongham Park, Woojin Kim, et al.
(2024)
Open Access | Times Cited: 1
A practical assessment protocol for clinically relevant P-glycoprotein-mediated drug-drug interactions
Leonie Bogaard, Kayan Tsoi, Bas van de Steeg, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Page 1

Scroll to top